APO Research

APO RESEARCH · REPORT

Non-Invasive BCI

Selected research

Market Analysis & Forecast

Global Non-Invasive BCI Market Analysis and Forecast 2026-2032

Market perspective

The global Non-Invasive BCI market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Non-Invasive BCI's global sales reached XX (k units) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned NIHON KOHDEN CORPORATION as the global sales leader, a title it has maintained for several consecutive years. Notably, NIHON KOHDEN CORPORATION's performance in primary markets is also remarkable. In the Chinese market, sales were XX (k units), a change of XX% from the previous year. In Europe, sales were XX (k units), showing a year-on-year of XX%. In the US, sales were XX (k units), a year-on-year change of XX%.

The major global manufacturers in the Non-Invasive BCI market include NIHON KOHDEN CORPORATION, Integra LifeSciences, Advanced Brain Monitoring, Cadwell Industries, OpenBCI, Cortech Solutions, NeuroSky, Emotiv and G.tec Medical Engineering GmbH, etc. In 2025, the top three vendors accounted for approximately % of the revenue.

Read the full market overview

In terms of production side, this report researches the Non-Invasive BCI production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of Non-Invasive BCI by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for Non-Invasive BCI, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Non-Invasive BCI, also provides the consumption of main regions and countries. Of the upcoming market potential for Non-Invasive BCI, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Non-Invasive BCI sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Non-Invasive BCI market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Non-Invasive BCI sales, projected growth trends, production technology, application and end-user industry.

Non-Invasive BCI Segment by Company

NIHON KOHDEN CORPORATION

Integra LifeSciences

Advanced Brain Monitoring

Cadwell Industries

OpenBCI

Cortech Solutions

NeuroSky

Emotiv

G.tec Medical Engineering GmbH

Natus Medical Incorporated

Non-Invasive BCI Segment by Type

EEG

FMRI

NIRS

MEG

ECOG

Non-Invasive BCI Segment by Application

Healthcare

Communication and Control

Entertainment and Gaming

Smart Home Control

Others

Non-Invasive BCI Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Invasive BCI market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-Invasive BCI and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Invasive BCI.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Non-Invasive BCI production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Non-Invasive BCI in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Non-Invasive BCI manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-Invasive BCI sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Non-Invasive BCI Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. EEG Major Manufacturers Table 3. FMRI Major Manufacturers Table 4. NIRS Major Manufacturers Table 5. MEG Major Manufacturers Table 6. ECOG Major Manufacturers Table 7. Global Non-Invasive BCI Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Healthcare Major Manufacturers Table 9. Communication and Control Major Manufacturers Table 10. Entertainment and Gaming Major Manufacturers Table 11. Smart Home Control Major Manufacturers Table 12. Others Major Manufacturers Table 13. Non-Invasive BCI Industry Trends Table 14. Non-Invasive BCI Industry Drivers Table 15. Non-Invasive BCI Industry Opportunities and Challenges Table 16. Non-Invasive BCI Industry Restraints Table 17. Global Non-Invasive BCI Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Non-Invasive BCI Production by Region (2021-2026) & (k units) Table 19. Global Non-Invasive BCI Production by Region (2027-2032) & (k units) Table 20. Global Non-Invasive BCI Production Market Share by Region (2021-2026) Table 21. Global Non-Invasive BCI Production Market Share by Region (2027-2032) Table 22. Global Non-Invasive BCI Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 23. Global Non-Invasive BCI Revenue by Region (2021-2026) & (US$ Million) Table 24. Global Non-Invasive BCI Revenue by Region (2027-2032) & (US$ Million) Table 25. Global Non-Invasive BCI Revenue Market Share by Region (2021-2026) Table 26. Global Non-Invasive BCI Revenue Market Share by Region (2027-2032) Table 27. Global Non-Invasive BCI Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 28. Global Non-Invasive BCI Sales by Region (2021-2026) & (k units) Table 29. Global Non-Invasive BCI Sales by Region (2027-2032) & (k units) Table 30. Global Non-Invasive BCI Sales Market Share by Region (2021-2026) Table 31. Global Non-Invasive BCI Sales Market Share by Region (2027-2032) Table 32. Global Non-Invasive BCI Revenue by Manufacturers (US$ Million) & (2021-2026) Table 33. Global Non-Invasive BCI Revenue Market Share by Manufacturers (2021-2026) Table 34. Global Non-Invasive BCI Sales by Manufacturers (US$ Million) & (2021-2026) Table 35. Global Non-Invasive BCI Sales Market Share by Manufacturers (2021-2026) Table 36. Global Non-Invasive BCI Sales Price (USD/unit) of Manufacturers (2021-2026) Table 37. Global Non-Invasive BCI Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 38. Global Non-Invasive BCI Key Manufacturers Manufacturing Sites & Headquarters Table 39. Global Non-Invasive BCI Manufacturers, Product Type & Application Table 40. Global Non-Invasive BCI Manufacturers Commercialization Time Table 41. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 42. Global Non-Invasive BCI by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 43. Global Non-Invasive BCI Revenue by Type (2021-2026) & (US$ Million) Table 44. Global Non-Invasive BCI Revenue by Type (2027-2032) & (US$ Million) Table 45. Global Non-Invasive BCI Revenue Market Share by Type (2021-2026) Table 46. Global Non-Invasive BCI Revenue Market Share by Type (2027-2032) Table 47. Global Non-Invasive BCI Sales by Type (2021-2026) & (k units) Table 48. Global Non-Invasive BCI Sales by Type (2027-2032) & (k units) Table 49. Global Non-Invasive BCI Sales Market Share by Type (2021-2026) Table 50. Global Non-Invasive BCI Sales Market Share by Type (2027-2032) Table 51. Global Non-Invasive BCI Price by Type (2021-2026) & (USD/unit) Table 52. Global Non-Invasive BCI Price by Type (2027-2032) & (USD/unit) Table 53. Global Non-Invasive BCI Revenue by Application (2021-2026) & (US$ Million) Table 54. Global Non-Invasive BCI Revenue by Application (2027-2032) & (US$ Million) Table 55. Global Non-Invasive BCI Revenue Market Share by Application (2021-2026) Table 56. Global Non-Invasive BCI Revenue Market Share by Application (2027-2032) Table 57. Global Non-Invasive BCI Sales by Application (2021-2026) & (k units) Table 58. Global Non-Invasive BCI Sales by Application (2027-2032) & (k units) Table 59. Global Non-Invasive BCI Sales Market Share by Application (2021-2026) Table 60. Global Non-Invasive BCI Sales Market Share by Application (2027-2032) Table 61. Global Non-Invasive BCI Price by Application (2021-2026) & (USD/unit) Table 62. Global Non-Invasive BCI Price by Application (2027-2032) & (USD/unit) Table 63. NIHON KOHDEN CORPORATION Company Information Table 64. NIHON KOHDEN CORPORATION Business Overview Table 65. NIHON KOHDEN CORPORATION Non-Invasive BCI Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. NIHON KOHDEN CORPORATION Non-Invasive BCI Product Portfolio Table 67. NIHON KOHDEN CORPORATION Recent Development Table 68. Integra LifeSciences Company Information Table 69. Integra LifeSciences Business Overview Table 70. Integra LifeSciences Non-Invasive BCI Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Integra LifeSciences Non-Invasive BCI Product Portfolio Table 72. Integra LifeSciences Recent Development Table 73. Advanced Brain Monitoring Company Information Table 74. Advanced Brain Monitoring Business Overview Table 75. Advanced Brain Monitoring Non-Invasive BCI Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Advanced Brain Monitoring Non-Invasive BCI Product Portfolio Table 77. Advanced Brain Monitoring Recent Development Table 78. Cadwell Industries Company Information Table 79. Cadwell Industries Business Overview Table 80. Cadwell Industries Non-Invasive BCI Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Cadwell Industries Non-Invasive BCI Product Portfolio Table 82. Cadwell Industries Recent Development Table 83. OpenBCI Company Information Table 84. OpenBCI Business Overview Table 85. OpenBCI Non-Invasive BCI Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. OpenBCI Non-Invasive BCI Product Portfolio Table 87. OpenBCI Recent Development Table 88. Cortech Solutions Company Information Table 89. Cortech Solutions Business Overview Table 90. Cortech Solutions Non-Invasive BCI Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Cortech Solutions Non-Invasive BCI Product Portfolio Table 92. Cortech Solutions Recent Development Table 93. NeuroSky Company Information Table 94. NeuroSky Business Overview Table 95. NeuroSky Non-Invasive BCI Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. NeuroSky Non-Invasive BCI Product Portfolio Table 97. NeuroSky Recent Development Table 98. Emotiv Company Information Table 99. Emotiv Business Overview Table 100. Emotiv Non-Invasive BCI Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Emotiv Non-Invasive BCI Product Portfolio Table 102. Emotiv Recent Development Table 103. G.tec Medical Engineering GmbH Company Information Table 104. G.tec Medical Engineering GmbH Business Overview Table 105. G.tec Medical Engineering GmbH Non-Invasive BCI Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. G.tec Medical Engineering GmbH Non-Invasive BCI Product Portfolio Table 107. G.tec Medical Engineering GmbH Recent Development Table 108. Natus Medical Incorporated Company Information Table 109. Natus Medical Incorporated Business Overview Table 110. Natus Medical Incorporated Non-Invasive BCI Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Natus Medical Incorporated Non-Invasive BCI Product Portfolio Table 112. Natus Medical Incorporated Recent Development Table 113. North America Non-Invasive BCI Revenue by Type (2021-2026) & (US$ Million) Table 114. North America Non-Invasive BCI Revenue by Type (2027-2032) & (US$ Million) Table 115. North America Non-Invasive BCI Sales by Type (2021-2026) & (k units) Table 116. North America Non-Invasive BCI Sales by Type (2027-2032) & (k units) Table 117. North America Non-Invasive BCI Sales Price by Type (2021-2026) & (USD/unit) Table 118. North America Non-Invasive BCI Sales Price by Type (2027-2032) & (USD/unit) Table 119. North America Non-Invasive BCI Revenue by Application (2021-2026) & (US$ Million) Table 120. North America Non-Invasive BCI Revenue by Application (2027-2032) & (US$ Million) Table 121. North America Non-Invasive BCI Sales by Application (2021-2026) & (k units) Table 122. North America Non-Invasive BCI Sales by Application (2027-2032) & (k units) Table 123. North America Non-Invasive BCI Sales Price by Application (2021-2026) & (USD/unit) Table 124. North America Non-Invasive BCI Sales Price by Application (2027-2032) & (USD/unit) Table 125. North America Non-Invasive BCI Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. North America Non-Invasive BCI Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 127. North America Non-Invasive BCI Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 128. North America Non-Invasive BCI Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 129. North America Non-Invasive BCI Sales by Country (2021-2026) & (k units) Table 130. North America Non-Invasive BCI Sales by Country (2027-2032) & (k units) Table 131. North America Non-Invasive BCI Sales Price by Country (2021-2026) & (USD/unit) Table 132. North America Non-Invasive BCI Sales Price by Country (2027-2032) & (USD/unit) Table 133. United States Non-Invasive BCI Revenue (2021-2032) & (US$ Million) Table 134. Canada Non-Invasive BCI Revenue (2021-2032) & (US$ Million) Table 135. Mexico Non-Invasive BCI Revenue (2021-2032) & (US$ Million) Table 136. Europe Non-Invasive BCI Revenue by Type (2021-2026) & (US$ Million) Table 137. Europe Non-Invasive BCI Revenue by Type (2027-2032) & (US$ Million) Table 138. Europe Non-Invasive BCI Sales by Type (2021-2026) & (k units) Table 139. Europe Non-Invasive BCI Sales by Type (2027-2032) & (k units) Table 140. Europe Non-Invasive BCI Sales Price by Type (2021-2026) & (USD/unit) Table 141. Europe Non-Invasive BCI Sales Price by Type (2027-2032) & (USD/unit) Table 142. Europe Non-Invasive BCI Revenue by Application (2021-2026) & (US$ Million) Table 143. Europe Non-Invasive BCI Revenue by Application (2027-2032) & (US$ Million) Table 144. Europe Non-Invasive BCI Sales by Application (2021-2026) & (k units) Table 145. Europe Non-Invasive BCI Sales by Application (2027-2032) & (k units) Table 146. Europe Non-Invasive BCI Sales Price by Application (2021-2026) & (USD/unit) Table 147. Europe Non-Invasive BCI Sales Price by Application (2027-2032) & (USD/unit) Table 148. Europe Non-Invasive BCI Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Europe Non-Invasive BCI Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 150. Europe Non-Invasive BCI Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 151. Europe Non-Invasive BCI Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 152. Europe Non-Invasive BCI Sales by Country (2021-2026) & (k units) Table 153. Europe Non-Invasive BCI Sales by Country (2027-2032) & (k units) Table 154. Europe Non-Invasive BCI Sales Price by Country (2021-2026) & (USD/unit) Table 155. Europe Non-Invasive BCI Sales Price by Country (2027-2032) & (USD/unit) Table 156. Germany Non-Invasive BCI Revenue (2021-2032) & (US$ Million) Table 157. France Non-Invasive BCI Revenue (2021-2032) & (US$ Million) Table 158. U.K. Non-Invasive BCI Revenue (2021-2032) & (US$ Million) Table 159. Italy Non-Invasive BCI Revenue (2021-2032) & (US$ Million) Table 160. Russia Non-Invasive BCI Revenue (2021-2032) & (US$ Million) Table 161. Spain Non-Invasive BCI Revenue (2021-2032) & (US$ Million) Table 162. Netherlands Non-Invasive BCI Revenue (2021-2032) & (US$ Million) Table 163. Switzerland Non-Invasive BCI Revenue (2021-2032) & (US$ Million) Table 164. Sweden Non-Invasive BCI Revenue (2021-2032) & (US$ Million) Table 165. Poland Non-Invasive BCI Revenue (2021-2032) & (US$ Million) Table 166. China Non-Invasive BCI Revenue by Type (2021-2026) & (US$ Million) Table 167. China Non-Invasive BCI Revenue by Type (2027-2032) & (US$ Million) Table 168. China Non-Invasive BCI Sales by Type (2021-2026) & (k units) Table 169. China Non-Invasive BCI Sales by Type (2027-2032) & (k units) Table 170. China Non-Invasive BCI Sales Price by Type (2021-2026) & (USD/unit) Table 171. China Non-Invasive BCI Sales Price by Type (2027-2032) & (USD/unit) Table 172. China Non-Invasive BCI Revenue by Application (2021-2026) & (US$ Million) Table 173. China Non-Invasive BCI Revenue by Application (2027-2032) & (US$ Million) Table 174. China Non-Invasive BCI Sales by Application (2021-2026) & (k units) Table 175. China Non-Invasive BCI Sales by Application (2027-2032) & (k units) Table 176. China Non-Invasive BCI Sales Price by Application (2021-2026) & (USD/unit) Table 177. China Non-Invasive BCI Sales Price by Application (2027-2032) & (USD/unit) Table 178. Asia Non-Invasive BCI Revenue by Type (2021-2026) & (US$ Million) Table 179. Asia Non-Invasive BCI Revenue by Type (2027-2032) & (US$ Million) Table 180. Asia Non-Invasive BCI Sales by Type (2021-2026) & (k units) Table 181. Asia Non-Invasive BCI Sales by Type (2027-2032) & (k units) Table 182. Asia Non-Invasive BCI Sales Price by Type (2021-2026) & (USD/unit) Table 183. Asia Non-Invasive BCI Sales Price by Type (2027-2032) & (USD/unit) Table 184. Asia Non-Invasive BCI Revenue by Application (2021-2026) & (US$ Million) Table 185. Asia Non-Invasive BCI Revenue by Application (2027-2032) & (US$ Million) Table 186. Asia Non-Invasive BCI Sales by Application (2021-2026) & (k units) Table 187. Asia Non-Invasive BCI Sales by Application (2027-2032) & (k units) Table 188. Asia Non-Invasive BCI Sales Price by Application (2021-2026) & (USD/unit) Table 189. Asia Non-Invasive BCI Sales Price by Application (2027-2032) & (USD/unit) Table 190. Asia Non-Invasive BCI Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. Asia Non-Invasive BCI Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 192. Asia Non-Invasive BCI Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 193. Asia Non-Invasive BCI Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 194. Asia Non-Invasive BCI Sales by Country (2021-2026) & (k units) Table 195. Asia Non-Invasive BCI Sales by Country (2027-2032) & (k units) Table 196. Asia Non-Invasive BCI Sales Price by Country (2021-2026) & (USD/unit) Table 197. Asia Non-Invasive BCI Sales Price by Country (2027-2032) & (USD/unit) Table 198. Japan Non-Invasive BCI Revenue (2021-2032) & (US$ Million) Table 199. South Korea Non-Invasive BCI Revenue (2021-2032) & (US$ Million) Table 200. India Non-Invasive BCI Revenue (2021-2032) & (US$ Million) Table 201. Australia Non-Invasive BCI Revenue (2021-2032) & (US$ Million) Table 202. Taiwan Non-Invasive BCI Revenue (2021-2032) & (US$ Million) Table 203. Southeast Asia Non-Invasive BCI Revenue (2021-2032) & (US$ Million) Table 204. SAMEA Non-Invasive BCI Revenue by Type (2021-2026) & (US$ Million) Table 205. SAMEA Non-Invasive BCI Revenue by Type (2027-2032) & (US$ Million) Table 206. SAMEA Non-Invasive BCI Sales by Type (2021-2026) & (k units) Table 207. SAMEA Non-Invasive BCI Sales by Type (2027-2032) & (k units) Table 208. SAMEA Non-Invasive BCI Sales Price by Type (2021-2026) & (USD/unit) Table 209. SAMEA Non-Invasive BCI Sales Price by Type (2027-2032) & (USD/unit) Table 210. SAMEA Non-Invasive BCI Revenue by Application (2021-2026) & (US$ Million) Table 211. SAMEA Non-Invasive BCI Revenue by Application (2027-2032) & (US$ Million) Table 212. SAMEA Non-Invasive BCI Sales by Application (2021-2026) & (k units) Table 213. SAMEA Non-Invasive BCI Sales by Application (2027-2032) & (k units) Table 214. SAMEA Non-Invasive BCI Sales Price by Application (2021-2026) & (USD/unit) Table 215. SAMEA Non-Invasive BCI Sales Price by Application (2027-2032) & (USD/unit) Table 216. SAMEA Non-Invasive BCI Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 217. SAMEA Non-Invasive BCI Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 218. SAMEA Non-Invasive BCI Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 219. SAMEA Non-Invasive BCI Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 220. SAMEA Non-Invasive BCI Sales by Country (2021-2026) & (k units) Table 221. SAMEA Non-Invasive BCI Sales by Country (2027-2032) & (k units) Table 222. SAMEA Non-Invasive BCI Sales Price by Country (2021-2026) & (USD/unit) Table 223. SAMEA Non-Invasive BCI Sales Price by Country (2027-2032) & (USD/unit) Table 224. Brazil Non-Invasive BCI Revenue (2021-2032) & (US$ Million) Table 225. Argentina Non-Invasive BCI Revenue (2021-2032) & (US$ Million) Table 226. Chile Non-Invasive BCI Revenue (2021-2032) & (US$ Million) Table 227. Colombia Non-Invasive BCI Revenue (2021-2032) & (US$ Million) Table 228. Peru Non-Invasive BCI Revenue (2021-2032) & (US$ Million) Table 229. Saudi Arabia Non-Invasive BCI Revenue (2021-2032) & (US$ Million) Table 230. Israel Non-Invasive BCI Revenue (2021-2032) & (US$ Million) Table 231. UAE Non-Invasive BCI Revenue (2021-2032) & (US$ Million) Table 232. Turkey Non-Invasive BCI Revenue (2021-2032) & (US$ Million) Table 233. Iran Non-Invasive BCI Revenue (2021-2032) & (US$ Million) Table 234. Egypt Non-Invasive BCI Revenue (2021-2032) & (US$ Million) Table 235. Key Raw Materials Table 236. Raw Materials Key Suppliers Table 237. Non-Invasive BCI Distributors List Table 238. Non-Invasive BCI Customers List Table 239. Research Programs/Design for This Report Table 240. Authors List of This Report Table 241. Secondary Sources Table 242. Primary Sources List of Figures Figure 1. Non-Invasive BCI Product Image Figure 2. Global Non-Invasive BCI Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-Invasive BCI Market Size Share 2021 VS 2025 VS 2032 Figure . EEG Image Figure 1. FMRI Image Figure 2. NIRS Image Figure 3. MEG Image Figure 4. ECOG Image Figure 5. Global Non-Invasive BCI Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Non-Invasive BCI Market Size Share 2021 VS 2025 VS 2032 Figure 7. Healthcare Image Figure 8. Communication and Control Image Figure 9. Entertainment and Gaming Image Figure 10. Smart Home Control Image Figure 11. Others Image Figure 12. Global Non-Invasive BCI Capacity, Capacity Utilization (2021-2032) & (k units) Figure 13. Global Non-Invasive BCI Production by Region: 2021 VS 2025 VS 2032 (k units) Figure 14. Global Non-Invasive BCI Production Market Share by Region: 2025 Versus 2032 Figure 15. Global Non-Invasive BCI Production Market Share by Region (2021-2032) Figure 16. North America Non-Invasive BCI Production Growth Rate (2021-2032) & (k units) Figure 17. Europe Non-Invasive BCI Production Growth Rate (2021-2032) & (k units) Figure 18. China Non-Invasive BCI Production Growth Rate (2021-2032) & (k units) Figure 19. Japan Non-Invasive BCI Production Growth Rate (2021-2032) & (k units) Figure 20. South Korea Non-Invasive BCI Production Growth Rate (2021-2032) & (k units) Figure 21. Global Non-Invasive BCI Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 22. Global Non-Invasive BCI Revenue (2021-2032) & (US$ Million) Figure 23. Global Non-Invasive BCI Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 24. Global Non-Invasive BCI Revenue Market Share by Region: 2025 Versus 2032 Figure 25. Global Non-Invasive BCI Revenue Market Share by Region (2021-2032) Figure 26. Global Non-Invasive BCI Sales (2021-2032) & (k units) Figure 27. Global Non-Invasive BCI Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Non-Invasive BCI Sales Market Share by Region (2021-2032) Figure 29. North America Non-Invasive BCI Sales YoY (2021-2032) & (k units) Figure 30. Europe Non-Invasive BCI Sales YoY (2021-2032) & (k units) Figure 31. China Non-Invasive BCI Sales YoY (2021-2032) & (k units) Figure 32. Asia (Excluding China) Non-Invasive BCI Sales YoY (2021-2032) & (k units) Figure 33. South America, Middle East and Africa Non-Invasive BCI Sales YoY (2021-2032) & (k units) Figure 34. Global Non-Invasive BCI Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 35. Global Non-Invasive BCI Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 36. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 37. Global Non-Invasive BCI Revenue Market Share by Type (2021-2032) Figure 38. Global Non-Invasive BCI Sales Market Share by Type (2021-2032) Figure 39. Global Non-Invasive BCI Revenue Market Share by Application (2021-2032) Figure 40. Global Non-Invasive BCI Sales Market Share by Application (2021-2032) Figure 41. North America Non-Invasive BCI Revenue Share by Type (2021-2032) Figure 42. North America Non-Invasive BCI Sales Share by Type (2021-2032) Figure 43. North America Non-Invasive BCI Revenue Share by Application (2021-2032) Figure 44. North America Non-Invasive BCI Sales Share by Application (2021-2032) Figure 45. North America Non-Invasive BCI Revenue Share by Country (2021-2032) Figure 46. North America Non-Invasive BCI Sales Share by Country (2021-2032) Figure 47. Europe Non-Invasive BCI Revenue Share by Type (2021-2032) Figure 48. Europe Non-Invasive BCI Sales Share by Type (2021-2032) Figure 49. Europe Non-Invasive BCI Revenue Share by Application (2021-2032) Figure 50. Europe Non-Invasive BCI Sales Share by Application (2021-2032) Figure 51. Europe Non-Invasive BCI Revenue Share by Country (2021-2032) Figure 52. Europe Non-Invasive BCI Sales Share by Country (2021-2032) Figure 53. China Non-Invasive BCI Revenue Share by Type (2021-2032) Figure 54. China Non-Invasive BCI Sales Share by Type (2021-2032) Figure 55. China Non-Invasive BCI Revenue Share by Application (2021-2032) Figure 56. China Non-Invasive BCI Sales Share by Application (2021-2032) Figure 57. Asia Non-Invasive BCI Revenue Share by Type (2021-2032) Figure 58. Asia Non-Invasive BCI Sales Share by Type (2021-2032) Figure 59. Asia Non-Invasive BCI Revenue Share by Application (2021-2032) Figure 60. Asia Non-Invasive BCI Sales Share by Application (2021-2032) Figure 61. Asia Non-Invasive BCI Revenue Share by Country (2021-2032) Figure 62. Asia Non-Invasive BCI Sales Share by Country (2021-2032) Figure 63. SAMEA Non-Invasive BCI Revenue Share by Type (2021-2032) Figure 64. SAMEA Non-Invasive BCI Sales Share by Type (2021-2032) Figure 65. SAMEA Non-Invasive BCI Revenue Share by Application (2021-2032) Figure 66. SAMEA Non-Invasive BCI Sales Share by Application (2021-2032) Figure 67. SAMEA Non-Invasive BCI Revenue Share by Country (2021-2032) Figure 68. SAMEA Non-Invasive BCI Sales Share by Country (2021-2032) Figure 69. Non-Invasive BCI Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Non-Invasive BCI Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • EEG
  • FMRI
  • NIRS
  • MEG
  • ECOG
Applications
  • Healthcare
  • Communication and Control
  • Entertainment and Gaming
  • Smart Home Control
  • Others
Companies covered
  • NIHON KOHDEN CORPORATION
  • Integra LifeSciences
  • Advanced Brain Monitoring
  • Cadwell Industries
  • OpenBCI
  • Cortech Solutions
  • NeuroSky
  • Emotiv
  • G.tec Medical Engineering GmbH
  • Natus Medical Incorporated

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Non-Invasive BCI Market by Type
  3. 1.2.1 Global Non-Invasive BCI Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 EEG
  5. 1.2.3 FMRI
  6. 1.2.4 NIRS
  7. 1.2.5 MEG
  8. 1.2.6 ECOG
  9. 1.3 Non-Invasive BCI Market by Application
  10. 1.3.1 Global Non-Invasive BCI Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Healthcare
  12. 1.3.3 Communication and Control
  13. 1.3.4 Entertainment and Gaming
  14. 1.3.5 Smart Home Control
  15. 1.3.6 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Non-Invasive BCI Market Dynamics
  1. 2.1 Non-Invasive BCI Industry Trends
  2. 2.2 Non-Invasive BCI Industry Drivers
  3. 2.3 Non-Invasive BCI Industry Opportunities and Challenges
  4. 2.4 Non-Invasive BCI Industry Restraints
3 Global Non-Invasive BCI Production Overview
  1. 3.1 Global Non-Invasive BCI Production Capacity (2021-2032)
  2. 3.2 Global Non-Invasive BCI Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global Non-Invasive BCI Production by Region
  4. 3.3.1 Global Non-Invasive BCI Production by Region (2021-2026)
  5. 3.3.2 Global Non-Invasive BCI Production by Region (2027-2032)
  6. 3.3.3 Global Non-Invasive BCI Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
  11. 3.8 South Korea
4 Global Market Growth Prospects
  1. 4.1 Global Non-Invasive BCI Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global Non-Invasive BCI Revenue by Region
  3. 4.2.1 Global Non-Invasive BCI Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global Non-Invasive BCI Revenue by Region (2021-2026)
  5. 4.2.3 Global Non-Invasive BCI Revenue by Region (2027-2032)
  6. 4.2.4 Global Non-Invasive BCI Revenue Market Share by Region (2021-2032)
  7. 4.3 Global Non-Invasive BCI Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global Non-Invasive BCI Sales by Region
  9. 4.4.1 Global Non-Invasive BCI Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global Non-Invasive BCI Sales by Region (2021-2026)
  11. 4.4.3 Global Non-Invasive BCI Sales by Region (2027-2032)
  12. 4.4.4 Global Non-Invasive BCI Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global Non-Invasive BCI Revenue by Manufacturers
  2. 5.1.1 Global Non-Invasive BCI Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global Non-Invasive BCI Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global Non-Invasive BCI Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global Non-Invasive BCI Sales by Manufacturers
  6. 5.2.1 Global Non-Invasive BCI Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global Non-Invasive BCI Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global Non-Invasive BCI Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global Non-Invasive BCI Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global Non-Invasive BCI Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global Non-Invasive BCI Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global Non-Invasive BCI Manufacturers, Product Type & Application
  13. 5.7 Global Non-Invasive BCI Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global Non-Invasive BCI Market CR5 and HHI
  16. 5.8.2 2025 Non-Invasive BCI Tier 1, Tier 2, and Tier 3
6 Non-Invasive BCI Market by Type
  1. 6.1 Global Non-Invasive BCI Revenue by Type
  2. 6.1.1 Global Non-Invasive BCI Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global Non-Invasive BCI Revenue Market Share by Type (2021-2032)
  4. 6.2 Global Non-Invasive BCI Sales by Type
  5. 6.2.1 Global Non-Invasive BCI Sales by Type (2021-2032) & (k units)
  6. 6.2.2 Global Non-Invasive BCI Sales Market Share by Type (2021-2032)
  7. 6.3 Global Non-Invasive BCI Price by Type
7 Non-Invasive BCI Market by Application
  1. 7.1 Global Non-Invasive BCI Revenue by Application
  2. 7.1.1 Global Non-Invasive BCI Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global Non-Invasive BCI Revenue Market Share by Application (2021-2032)
  4. 7.2 Global Non-Invasive BCI Sales by Application
  5. 7.2.1 Global Non-Invasive BCI Sales by Application (2021-2032) & (k units)
  6. 7.2.2 Global Non-Invasive BCI Sales Market Share by Application (2021-2032)
  7. 7.3 Global Non-Invasive BCI Price by Application
8 Company Profiles
  1. 8.1 NIHON KOHDEN CORPORATION
  2. 8.1.1 NIHON KOHDEN CORPORATION Company Information
  3. 8.1.2 NIHON KOHDEN CORPORATION Business Overview
  4. 8.1.3 NIHON KOHDEN CORPORATION Non-Invasive BCI Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 NIHON KOHDEN CORPORATION Non-Invasive BCI Product Portfolio
  6. 8.1.5 NIHON KOHDEN CORPORATION Recent Developments
  7. 8.2 Integra LifeSciences
  8. 8.2.1 Integra LifeSciences Company Information
  9. 8.2.2 Integra LifeSciences Business Overview
  10. 8.2.3 Integra LifeSciences Non-Invasive BCI Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 Integra LifeSciences Non-Invasive BCI Product Portfolio
  12. 8.2.5 Integra LifeSciences Recent Developments
  13. 8.3 Advanced Brain Monitoring
  14. 8.3.1 Advanced Brain Monitoring Company Information
  15. 8.3.2 Advanced Brain Monitoring Business Overview
  16. 8.3.3 Advanced Brain Monitoring Non-Invasive BCI Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 Advanced Brain Monitoring Non-Invasive BCI Product Portfolio
  18. 8.3.5 Advanced Brain Monitoring Recent Developments
  19. 8.4 Cadwell Industries
  20. 8.4.1 Cadwell Industries Company Information
  21. 8.4.2 Cadwell Industries Business Overview
  22. 8.4.3 Cadwell Industries Non-Invasive BCI Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 Cadwell Industries Non-Invasive BCI Product Portfolio
  24. 8.4.5 Cadwell Industries Recent Developments
  25. 8.5 OpenBCI
  26. 8.5.1 OpenBCI Company Information
  27. 8.5.2 OpenBCI Business Overview
  28. 8.5.3 OpenBCI Non-Invasive BCI Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 8.5.4 OpenBCI Non-Invasive BCI Product Portfolio
  30. 8.5.5 OpenBCI Recent Developments
  31. 8.6 Cortech Solutions
  32. 8.6.1 Cortech Solutions Company Information
  33. 8.6.2 Cortech Solutions Business Overview
  34. 8.6.3 Cortech Solutions Non-Invasive BCI Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 8.6.4 Cortech Solutions Non-Invasive BCI Product Portfolio
  36. 8.6.5 Cortech Solutions Recent Developments
  37. 8.7 NeuroSky
  38. 8.7.1 NeuroSky Company Information
  39. 8.7.2 NeuroSky Business Overview
  40. 8.7.3 NeuroSky Non-Invasive BCI Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 8.7.4 NeuroSky Non-Invasive BCI Product Portfolio
  42. 8.7.5 NeuroSky Recent Developments
  43. 8.8 Emotiv
  44. 8.8.1 Emotiv Company Information
  45. 8.8.2 Emotiv Business Overview
  46. 8.8.3 Emotiv Non-Invasive BCI Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 8.8.4 Emotiv Non-Invasive BCI Product Portfolio
  48. 8.8.5 Emotiv Recent Developments
  49. 8.9 G.tec Medical Engineering GmbH
  50. 8.9.1 G.tec Medical Engineering GmbH Company Information
  51. 8.9.2 G.tec Medical Engineering GmbH Business Overview
  52. 8.9.3 G.tec Medical Engineering GmbH Non-Invasive BCI Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 8.9.4 G.tec Medical Engineering GmbH Non-Invasive BCI Product Portfolio
  54. 8.9.5 G.tec Medical Engineering GmbH Recent Developments
  55. 8.10 Natus Medical Incorporated
  56. 8.10.1 Natus Medical Incorporated Company Information
  57. 8.10.2 Natus Medical Incorporated Business Overview
  58. 8.10.3 Natus Medical Incorporated Non-Invasive BCI Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 8.10.4 Natus Medical Incorporated Non-Invasive BCI Product Portfolio
  60. 8.10.5 Natus Medical Incorporated Recent Developments
9 North America
  1. 9.1 North America Non-Invasive BCI Market Size by Type
  2. 9.1.1 North America Non-Invasive BCI Revenue by Type (2021-2032)
  3. 9.1.2 North America Non-Invasive BCI Sales by Type (2021-2032)
  4. 9.1.3 North America Non-Invasive BCI Price by Type (2021-2032)
  5. 9.2 North America Non-Invasive BCI Market Size by Application
  6. 9.2.1 North America Non-Invasive BCI Revenue by Application (2021-2032)
  7. 9.2.2 North America Non-Invasive BCI Sales by Application (2021-2032)
  8. 9.2.3 North America Non-Invasive BCI Price by Application (2021-2032)
  9. 9.3 North America Non-Invasive BCI Market Size by Country
  10. 9.3.1 North America Non-Invasive BCI Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America Non-Invasive BCI Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America Non-Invasive BCI Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe Non-Invasive BCI Market Size by Type
  2. 10.1.1 Europe Non-Invasive BCI Revenue by Type (2021-2032)
  3. 10.1.2 Europe Non-Invasive BCI Sales by Type (2021-2032)
  4. 10.1.3 Europe Non-Invasive BCI Price by Type (2021-2032)
  5. 10.2 Europe Non-Invasive BCI Market Size by Application
  6. 10.2.1 Europe Non-Invasive BCI Revenue by Application (2021-2032)
  7. 10.2.2 Europe Non-Invasive BCI Sales by Application (2021-2032)
  8. 10.2.3 Europe Non-Invasive BCI Price by Application (2021-2032)
  9. 10.3 Europe Non-Invasive BCI Market Size by Country
  10. 10.3.1 Europe Non-Invasive BCI Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe Non-Invasive BCI Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe Non-Invasive BCI Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China Non-Invasive BCI Market Size by Type
  2. 11.1.1 China Non-Invasive BCI Revenue by Type (2021-2032)
  3. 11.1.2 China Non-Invasive BCI Sales by Type (2021-2032)
  4. 11.1.3 China Non-Invasive BCI Price by Type (2021-2032)
  5. 11.2 China Non-Invasive BCI Market Size by Application
  6. 11.2.1 China Non-Invasive BCI Revenue by Application (2021-2032)
  7. 11.2.2 China Non-Invasive BCI Sales by Application (2021-2032)
  8. 11.2.3 China Non-Invasive BCI Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia Non-Invasive BCI Market Size by Type
  2. 12.1.1 Asia Non-Invasive BCI Revenue by Type (2021-2032)
  3. 12.1.2 Asia Non-Invasive BCI Sales by Type (2021-2032)
  4. 12.1.3 Asia Non-Invasive BCI Price by Type (2021-2032)
  5. 12.2 Asia Non-Invasive BCI Market Size by Application
  6. 12.2.1 Asia Non-Invasive BCI Revenue by Application (2021-2032)
  7. 12.2.2 Asia Non-Invasive BCI Sales by Application (2021-2032)
  8. 12.2.3 Asia Non-Invasive BCI Price by Application (2021-2032)
  9. 12.3 Asia Non-Invasive BCI Market Size by Country
  10. 12.3.1 Asia Non-Invasive BCI Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia Non-Invasive BCI Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia Non-Invasive BCI Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA Non-Invasive BCI Market Size by Type
  2. 13.1.1 SAMEA Non-Invasive BCI Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA Non-Invasive BCI Sales by Type (2021-2032)
  4. 13.1.3 SAMEA Non-Invasive BCI Price by Type (2021-2032)
  5. 13.2 SAMEA Non-Invasive BCI Market Size by Application
  6. 13.2.1 SAMEA Non-Invasive BCI Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA Non-Invasive BCI Sales by Application (2021-2032)
  8. 13.2.3 SAMEA Non-Invasive BCI Price by Application (2021-2032)
  9. 13.3 SAMEA Non-Invasive BCI Market Size by Country
  10. 13.3.1 SAMEA Non-Invasive BCI Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA Non-Invasive BCI Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA Non-Invasive BCI Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 Non-Invasive BCI Value Chain Analysis
  2. 14.1.1 Non-Invasive BCI Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 Non-Invasive BCI Production Mode & Process
  6. 14.2 Non-Invasive BCI Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 Non-Invasive BCI Distributors
  9. 14.2.3 Non-Invasive BCI Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research